首页> 美国卫生研究院文献>Antimicrobial Resistance and Infection Control >First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

【2h】

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

机译：在暴露于RALTEGRAVIR之后在喀麦隆的第一种情况下Dolututgravir和Darunavir / R多药物耐药HIV-1：课程和对基于DoluteGravir的时期的课程和影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

CD4-cell and viral load monitoring, ART regimens, and resistance profiles since ART-initiation

机译：CD4细胞和病毒载荷监测，艺术方案和抗性曲线以来自艺术启动以来

著录项

期刊名称 Antimicrobial Resistance and Infection Control
作者
Joseph Fokam; Desire Takou; Ezechiel Ngoufack Jagni Semengue; Georges Teto; Grace Beloumou; Beatrice Dambaya; Maria-Mercedes Santoro; Leonella Mossiang; Serge Clotaire Billong; Fatim Cham; Samuel Martin Sosso; Edith Saounde Temgoua; Aubin Joseph Nanfack; Sylvie Moudourou; Nelly Kamgaing; Rachel Kamgaing; Joelle Nounouce Ngako Pamen; Mireille Mpoudi Ngole Etame; Anne-Cecile Z.-K. Bissek; Jean-Bosco N. Elat; Emmanuel Eben Moussi; Vittorio Colizzi; Carlo-Federico Perno; Alexis Ndjolo;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类药学;
关键词

机译：艾滋病毒耐药;整合酶抑制剂;蛋白酶抑制剂;病毒性的覆革症;喀麦隆;

相似文献

外文文献
中文文献

1. First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens [J] . Joseph Fokam, Desire Takou, Ezechiel Ngoufack Jagni Semengue, Antimicrobial Resistance and Infection Control . 2020,第1期

机译：在暴露于RALTEGRAVIR之后，在喀麦隆的第一种情况下Dolututgravir和Darunavir / R多药物耐药HIV-1：课程和对基于DoluteGravir的时期的课程和影响
2. Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1 [J] . Pinnetti Carmela, Tintoni Mauro, Ammassari Adriana, AIDS . 2015,第18期

机译：基于dolutegravir的联合抗逆转录病毒疗法在多类高度耐药的HIV-1垂直感染孕妇中成功预防HIV母婴传播
3. Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana [J] . Seatla Kaelo K., Avalos Ava, Moyo Sikhulile, AIDS . 2018,第13期

机译：治疗中的四类耐药HIV-1亚型C在博茨瓦纳基于Dolututgravir的抗逆转录病毒治疗
4. Determination of Post-Exposure Prophylaxis Regimen in the Prevention of Potential Pediatric HIV-1 Infection by the Multi-criteria Decision Making Theory [C] . Murat Sayan, Nazife Sultanoglu, Berna Uzun, Advances in Science and Engineering Technology International Conferences . 2019

机译：多准则决策理论确定预防儿童小儿HIV-1感染的暴露后预防方案
5. Comparative Changes of Lipid Levels in Treatment-Naive HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz Raltegravir and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks [O] . Romina Quercia, Jeremy Roberts, Louise Martin-Carpenter, -1

机译：在多于48周的时间里用多洛格韦与依夫韦伦拉格韦和以利托那韦增强的达鲁那韦治疗的未经治疗的感染HIV-1的成年人血脂水平的比较变化
6. First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens [O] . Joseph Fokam, Desire Takou, Ezechiel Ngoufack Jagni Semengue, 2020

机译：在暴露于RALTEGRAVIR之后，在喀麦隆的第一种情况下Dolututgravir和Darunavir / R多药物耐药HIV-1：课程和对基于DoluteGravir的时期的课程和影响

First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens

摘要

著录项

相似文献

相关主题

期刊订阅